Lazard Asset Management’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.97M | Sell |
435,669
-46,968
| -10% | -$751K | 0.01% | 642 |
|
|
2025
Q1 | $9.38M | Buy |
482,637
+285,149
| +144% | +$5.54M | 0.01% | 504 |
|
|
2024
Q4 | $4.35M | Buy |
197,488
+7,058
| +4% | +$155K | 0.01% | 673 |
|
|
2024
Q3 | $3.21M | Sell |
190,430
-113,526
| -37% | -$1.91M | ﹤0.01% | 746 |
|
|
2024
Q2 | $3.63M | Buy |
303,956
+282,259
| +1,301% | +$3.37M | ﹤0.01% | 749 |
|
|
2024
Q1 | $240K | Buy |
21,697
+4,842
| +29% | +$53.6K | ﹤0.01% | 1242 |
|
|
2023
Q4 | $145K | Sell |
16,855
-13,798
| -45% | -$119K | ﹤0.01% | 1508 |
|
|
2023
Q3 | $234K | Buy |
30,653
+3,005
| +11% | +$22.9K | ﹤0.01% | 1338 |
|
|
2023
Q2 | $199K | Buy |
27,648
+13,405
| +94% | +$96.5K | ﹤0.01% | 1347 |
|
|
2023
Q1 | $86K | Buy |
14,243
+6,749
| +90% | +$40.8K | ﹤0.01% | 1589 |
|
|
2022
Q4 | $32K | Buy |
+7,494
| New | +$32K | ﹤0.01% | 1986 |
|